Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis-Reference-Cited by-同舟云学术

Major bleeding risks of different low‐molecular‐weight heparin agents: a cohort study in 12 934 patients treated for acute venous thrombosis

Author:

Rein N.¹²,Biedermann J. S.³⁴,Meer F. J. M.¹,Cannegieter S. C.⁵,Wiersma N.⁶,Vermaas H. W.⁷,Reitsma P. H.¹²,Kruip M. J. H. A.³⁴,Lijfering W. M.¹²⁵

Affiliation:

1. Department of Thrombosis and Hemostasis Leiden University Medical Center Leiden the Netherlands

2. Einthoven Laboratory for Experimental Vascular Medicine Leiden University Medical Center Leiden the Netherlands

3. Department of Hematology Erasmus University Medical Center Rotterdam the Netherlands

4. Star‐Medical Diagnostic Center Rotterdam the Netherlands

5. Department of Clinical Epidemiology Leiden University Medical Center Leiden the Netherlands

6. Anticoagulation Clinic Utrecht Utrecht the Netherlands

7. Anticoagulation Clinic The Hague The Hague the Netherlands

Funder

Center for Translational Molecular Medicine

Publisher

Wiley

Subject

Hematology

Link

Reference15 articles.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献